Study title: A Double-Blind Multicenter Group Comparison Study of the Safety and Effectiveness of 0,5% Nedocromil Sodium Nebulizer Solution QID vs. Placebo in the Management of Bronchila Asthma in Children (6-12 Years old), 1993, Medical Report
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: NEDOCROMIL | |||||
ATC code: R01AC07 | |||||
Document link: | |||||
Document date: 2013-01-24 | |||||
Study number: CR 1574 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |